Skip to content

Effect of multimodal comprehensive treatment on gastrointestinal function in critically ill patients

Effect of multimodal comprehensive treatment on gastrointestinal function in critically ill patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107484
Enrollment
Unknown
Registered
2025-08-12
Start date
2024-09-25
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired gastrointestinal function

Interventions

Critical care group:According to the clinical needs, western medicine treatment (Doumicide, mosapride, compound enzyme, bifidobacterium triple viable bacteria, etc.), traditional Chinese medicine trea
Healthy group: :There was no intervention, and the patients were followed up for gastrointestinal electrocardiogram and 16s gene detection of intestinal bacteria.

Sponsors

Xiamen Branch, Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Critical group: 1.Critically ill patients in ICU, ICU length of stay more than 7 days; 2.Male and female are not limited, try to maintain a 1:1 ratio; 3.The age ranged from 18 to 85 years. Healthy group: 1.Healthy physical examination; 2.The age ranged from 18 to 85 years.

Exclusion criteria

Exclusion criteria: Critical group: 1.Perianal infection; 2.Patients with gastrointestinal fistula; 3.Other treatments contrary to the inclusion criteria, comorbidities, and pregnancy. Healthy group: 1.Without metabolic diseases (diabetes, hyperthyroidism, etc.); 2.Antibiotics, probiotics, enteral nutrition and other drugs were taken within 3 months.3.Subjects' request to withdraw informed consent; 4.It is necessary for the researcher to stop the study from the medical point of view.

Design outcomes

Primary

MeasureTime frame
Gastrointestinal status;Sequencing of intestinal flora diversity;

Secondary

MeasureTime frame
Lactic acid;

Countries

China

Contacts

Public ContactZhang Lianfang

Xiamen Branch, Zhongshan Hospital, Fudan University

zhang.lianfang@zsxmhospital.com+86 188 0502 0763

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026